Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Drug-resistant TB news

Show

From To
USAID announces new partnerships to combat MDR-TB

At last week’s launch of the National Action Plan for Combating Multidrug-Resistant Tuberculosis, the U.S. Agency for International Development announced expanded partnerships with Janssen, the maker of bedaquiline, the first tuberculosis drug to be produced since the 1950s, and Cepheid, maker of the GeneXpert rapid diagnostic test for drug-resistant tuberculosis.

Published
13 January 2016
From
Science Speaks
TAG’s Response to the U.S. Action Plan for Combating Multidrug Resistant Tuberculosis

Treatment Action Group (TAG) welcomes the release of the Obama Administration’s National Action Plan for Combating Multidrug-Resistant Tuberculosis. Strengthening the domestic and global and research efforts to address multidrug-resistant tuberculosis (MDR-TB) are critical to ending the suffering this preventable, curable disease needlessly causes. However, the targets set forth in this plan are not ambitious enough to effectively stop the spread of MDR-TB.

Published
11 January 2016
From
Treatment Action Group
First new TB drugs in half a century reach just 2% of people who need them

MSF calls for companies to make new drugs to treat drug-resistant TB available and affordable.

Published
04 December 2015
From
MSF
New cohort study shows promise of dramatically shorter treatment option for multidrug - resistant TB

New findings from clinical studies presented at the 46th Union World Conference on Lung Health show promise for a shorter, 9 -month treatment course for MDR-TB. The standard treatment length recommended by the World Health Organization requires 24 months of treatment.

Published
03 December 2015
From
46th Union World Conference on Lung Health
New survey shows outdated TB policies and practices risking further spread of drug-resistant TB

Urgent phase-out needed for outdated policies of mandatory hospitalisation, re-treatment regimens that contribute to drug resistance, and sub-optimal diagnosis.

Published
03 December 2015
From
MSF
Bulk of world’s MDR-TB cases undiagnosed – WHO

The world may be losing the war against the rise of drug-resistant tuberculosis (TB) as the bulk of patients with multidrug-resistant TB go undiagnosed, according to the World Health Organisation’s (WHO) latest TB report.

Published
28 October 2015
From
Health-E News
Nonprofit Gets Back Drug and Reverses 18-Fold Increase in Price

A nonprofit in Indiana has dropped the price of a drug for multi-drug resistant tuberculosis roughly 90% after re-acquiring rights to the medicine from Rodelis Therapeutics, the latest sign of a growing outcry over skyrocketing costs for rare disease treatments.

Published
22 September 2015
From
Bloomberg
NHS England commissions first new TB drugs in 50 years

NHS England has published a new Clinical Commissioning Policy making Janssen’s Sirturo and Otsuka’s Deltyba routinely available on the National Health Service for the treatment of pulmonary multi-drug resistant tuberculosis, offering patients easier access to the first novel therapies in nearly 50 years.

Published
25 August 2015
From
Pharma Times
Medicines Patent Pool At 5 Years: Promises Kept, Changes Ahead – An Interview With Greg Perry

The Medicines Patent Pool in Geneva is celebrating five years of existence this month. MPP Executive Director Greg Perry sat down with Intellectual Property Watch Catherine Saez to describe progress made since its inception, the success of its licensing agreement model, and plans for the future, including a possible extension to other diseases such as tuberculosis and hepatitis C.

Published
04 August 2015
From
Intellectual Property Watch
Ambitious new U.S. plan may put hundreds of thousands on MDR-TB treatment

The United States plans to place 360,000 multidrug-resistant tuberculosis patients globally on treatment over the next five years, as part of a national tuberculosis action plan currently under draft.

Published
27 July 2015
From
Science Speaks
← First12345...17Next →

Filter by country